Toshifumi Kimura
About
Toshifumi Kimura is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health.
According to data from OpenAlex, Toshifumi Kimura has authored 38 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 5 papers in Psychiatry and Mental health. Recurrent topics in Toshifumi Kimura's work include Receptor Mechanisms and Signaling (15 papers), Neuropeptides and Animal Physiology (10 papers) and Neuroscience and Neuropharmacology Research (7 papers). Toshifumi Kimura is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Neuropeptides and Animal Physiology (10 papers) and Neuroscience and Neuropharmacology Research (7 papers). Toshifumi Kimura collaborates with scholars based in Japan, United States and United Kingdom. Toshifumi Kimura's co-authors include Hiroshi Kawamoto, Gentaroh Suzuki, Hisashi Ohta, Y. Tokura, Satoshi Yamaguchi, Y. Okimoto, H. Takagi, Hiromi Taniguchi, Akio Satow and Shunsuke Maehara and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Physical review. B, Condensed matter.
In The Last Decade
Toshifumi Kimura
38 papers receiving 879 citations
Peers
Toshifumi Kimura
Jeffrey A. McKinney United States
Yuxuan Zhuang China
M. Hata Japan
Michael P. Maher United States
Hiroshi Kitaguchi Japan
Paolo Carrara France
Akiko Fukushima Japan
Yuji Kaneko Japan
F.A. Jove United States
T.R. Cummins United States
Citations per year, relative to Toshifumi Kimura Toshifumi Kimura (= 1×)
peers
Jeffrey A. McKinney
Countries citing papers authored by Toshifumi Kimura
Since
Specialization
Citations
This map shows the geographic impact of Toshifumi Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshifumi Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshifumi Kimura more than expected).
Fields of papers citing papers by Toshifumi Kimura
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Toshifumi Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshifumi Kimura. The network helps show where Toshifumi Kimura may publish in the future.
Co-authorship network of co-authors of Toshifumi Kimura
This figure shows the co-authorship network connecting the top 25 collaborators of Toshifumi Kimura. A scholar is included among the top collaborators of Toshifumi Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshifumi Kimura. Toshifumi Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kimura, Toshifumi, et al.. (2023). Abstract 2699: FF-10850, a dihydrosphingomyelin (DHSM)-based novel liposomal topotecan, achieved favorable efficacy and safety in combination with platinum, PARP and immune checkpoint inhibitors. Cancer Research. 83(7_Supplement). 2699–2699.
2.
Masuo, Yusuke, et al.. (2022). A physiologically based pharmacokinetic and pharmacodynamic model for disposition of FF-10832. International Journal of Pharmaceutics. 627. 122250–122250.
3.
Terao, Takeshi, et al.. (2017). Preventive Effects of Lamotrigine in Bipolar II Versus Bipolar I Disorder. The Journal of Clinical Psychiatry. 78(8). e1000–e1005.
4.
Terao, Takeshi, et al.. (2017). Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report. Neuropsychiatric Disease and Treatment. Volume 13. 1441–1448.
5.
Kimura, Toshifumi, et al.. (2015). Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression. Neuropsychiatric Disease and Treatment. 11. 435–435.
6.
Ito, Satoru, Yasushi Nagatomi, Atsushi Satoh, et al.. (2009). Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: A potential treatment for psychotic disorders. Bioorganic & Medicinal Chemistry Letters. 19(18). 5310–5313.
7.
Satoh, Atsushi, Yasushi Nagatomi, Gentaroh Suzuki, et al.. (2009). Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist. Bioorganic & Medicinal Chemistry Letters. 19(18). 5464–5468.
8.
Suzuki, Gentaroh, Toshifumi Kimura, Hirohiko Hikichi, et al.. (2009). Correlation of Receptor Occupancy of Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Mouse Brain With In Vivo Activity of Allosteric mGluR1 Antagonists. Journal of Pharmacological Sciences. 110(3). 315–325.
9.
Fukuda, Junko, Gentaroh Suzuki, Toshifumi Kimura, et al.. (2009). Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one. Neuropharmacology. 57(4). 438–445.
10.
Ito, Satoru, Atsushi Satoh, Yasushi Nagatomi, et al.. (2008). Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist. Bioorganic & Medicinal Chemistry. 16(22). 9817–9829.
11.
Suzuki, Gentaroh, Toshifumi Kimura, Akio Satow, et al.. (2007). Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1 H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2 H)-carboxamide (FTIDC). Journal of Pharmacology and Experimental Therapeutics. 321(3). 1144–1153.
12.
Sagara, Takeshi, Sachie Otsuki, Toshifumi Kimura, et al.. (2006). Identification of a Novel 4-Aminomethylpiperidine Class of M3Muscarinic Receptor Antagonists and Structural Insight into Their M3Selectivity. Journal of Medicinal Chemistry. 49(19). 5653–5663.
13.
Denda‐Nagai, Kaori, et al.. (2006). Properties of Blocking and Non-blocking Monoclonal Antibodies Specific for Human Macrophage Galactose-type C-type Lectin (MGL/ClecSF10A/CD301). The Journal of Biochemistry. 141(1). 127–136.
14.
Kimura, Toshifumi, et al.. (2003). Identification of novel muscarinic M3 selective antagonists with a conformationally restricted Hyp-Pro spacer. Bioorganic & Medicinal Chemistry Letters. 13(1). 57–60.
15.
Hirose, Hiroyasu, Ikuo Aoki, Toshifumi Kimura, et al.. (2002). The subtypes of muscarinic receptors for neurogenic bladder contraction in rats. European Journal of Pharmacology. 452(2). 245–253.
16.
Mitsuya, Morihiro, Yoshio Ogino, Toshifumi Kimura, et al.. (2000). Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivatives. Bioorganic & Medicinal Chemistry. 8(4). 825–832.
17.
Hirose, Hiroyasu, Toshifumi Kimura, Megumu Okada, et al.. (2000). Antiplatelet and Antithrombotic Effects of a Novel Selective Phosphodiesterase 3 Inhibitor, NSP-513, in Mice and Rats. The Japanese Journal of Pharmacology. 82(3). 188–198.
18.
Kimura, Toshifumi, et al.. (2000). Epitope mapping of monoclonal antibodies specific for a macrophage lectin: a calcium-dependent epitope is in the carbohydrate recognition domain. Molecular Immunology. 37(3-4). 151–160.
19.
Kimura, Toshifumi, Yasuyuki Imai, & Tatsuro Irimura. (1995). Calcium-dependent Conformation of a Mouse Macrophage Calcium-type Lectin. Journal of Biological Chemistry. 270(27). 16056–16062.
20.
Imai, Yoichi, et al.. (1995). Restricted expression of galactose/N-acetylgalactosamine-specific macrophage C-type lectin to connective tissue and to metastatic lesions in mouse lung.. PubMed. 86(4). 591–8.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jeffrey A. McKinney Breakdown of academic impact, for papers by Yuxuan Zhuang Breakdown of academic impact, for papers by M. Hata Breakdown of academic impact, for papers by Michael P. Maher Breakdown of academic impact, for papers by Hiroshi Kitaguchi Breakdown of academic impact, for papers by Paolo Carrara Breakdown of academic impact, for papers by Akiko Fukushima Breakdown of academic impact, for papers by Yuji Kaneko Breakdown of academic impact, for papers by F.A. Jove Breakdown of academic impact, for papers by T.R. Cummins